Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,400 reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted July 22, 2024
Umary Hyaluronic Acid Supplement Recalled
(See ConsumerLab’s Review of Joint Health Supplements for more information about hyaluronic acid and tests of related supplements.)
Diclofenac is an anti-inflammatory drug (also known as NSAIDs) and consumption of high levels could result in serious adverse events. Cardiovascular, gastrointestinal, renal, and anaphylaxis issues may occur for those taking NSAIDs and/ or anticoagulants. This includes consumers with underlying cardiovascular, gastrointestinal, renal and hepatic illness.
Omeprazole is a proton pump inhibitor (also known as PPI) and is used for stomach acid disorders. PPI medications may cause skin reactions, abdominal pain, diarrhea, nausea, and headache. Omeprazole should not be taken with certain medications as it may hide potential stomach issues including erosions, ulcers, or stomach cancer.
Umary Hyaluronic Acid (see product photos) is packaged in bottles with 30 850-mg capsules and were sold online nationwide. Consumers who have this product are advised to stop use immediately.
Umary Hyaluronic Acid was previously recalled in Canada, in May 2024, after a consumer reported experiencing an adverse reaction to the supplement and testing by Health Canada (the Canadian equivalent of the U.S. FDA) revealed the presence of diclofenac and omeprazole in the supplement.
The company is notifying consumers via email, arranging for the return of the products.
Consumers should contact their healthcare provider if they have experienced any problems related to taking these drug products. Consumers and or healthcare providers are advised to report any adverse reactions to the FDA’s MedWatch Voluntary Reporting Program by fax, mail, or online.
Also see ConsumerLab’s article about supplements promoted to help with arthritis
For more information, use the link below.
SoloVital.com Issues Voluntary Nationwide Recall of Umary Acido Hialuronica, Suplemento Alimenticio 850 mg Capsules Due to the Presence of Undeclared Drug Ingredients: Diclofenac and Omeprazole
See related recalls and warnings:
Drug Found in Umary Supplement
Pain Relief Tea Recalled, Found to Contain Prescription Drugs
Joint Pain Supplements Recalled Due to Undeclared Drug Ingredients
FDA Warns Consumers Not to Use Tapee Tea
Toxic Herb Found In Weight Supplements
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
If you believe that a dietary supplement (e.g., vitamin, mineral, or herbal supplement) or other nutritional product has caused an unexpected, adverse reaction, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their Safety Reporting Portal at https://www.safetyreporting.hhs.gov.
Please complete the form below as accurately as possible. You may need to check the label on the product.
Thank you for submitting your report.
Generic Drug Problem Report
If you believe that a generic drug has not acted like the original drug, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their MedWatch program at the FDA MedWatch website.
Please complete the form below as accurately as possible. You may need to check the label on the drug.
Thank you for submitting your report.
